MORPHOMETRIC CHANGES IN THE TESTIS AGAINST THE BACKGROUND OF CHEMOTHERAPY-INDUCED RENAL FAILURE AND THEIR BIOCORRECTION
Downloads
Objective: This study investigates the effects of chemotherapy-induced renal impairment on testicular morphology and evaluates the efficacy of a biocorrective intervention aimed at mitigating associated reproductive damage. Method: Conducted at the Department of Trauma Outcomes and Orthopaedics, Surkhandarya Multidisciplinary Medical Centre, the study utilized an animal model to simulate cytotoxic therapy-induced renal failure. Histological and morphometric analyses of testicular tissue were performed, focusing on parameters such as seminiferous tubule diameter, spermatogenic stratification, and interstitial cell function. A biocorrective agent with antioxidant properties was administered to assess restorative outcomes. Results: Chemotherapy-induced renal dysfunction resulted in significant structural alterations in the testes, including reduced spermatogenic activity and cellular degeneration. Treatment with the biocorrective compound led to partial restoration of testicular architecture and improved cellular integrity. Novelty: The study provides new insights into the systemic consequences of chemotherapy, particularly its underrecognized impact on male reproductive health, and demonstrates the therapeutic potential of targeted biocorrection in preserving gonadal function. These findings support a more integrative, organ-preserving approach in oncology care that prioritizes long-term quality of life alongside cancer eradication.
A. Khan, S. Alshahrani, M. H. Alqahtani, et al., “Chemotherapy-induced nephrotoxicity: mechanisms, biomarkers, and prevention strategies,” Front. Pharmacol., vol. 13, p. 931290, 2022, doi: 10.3389/fphar.2022.931290.
S. Kumar, R. Prasad, and R. K. Srivastava, “Oxidative stress and testicular dysfunction: a novel perspective on chemotherapy-induced male infertility,” Reprod. Biol. Endocrinol., vol. 19, no. 1, p. 56, 2021, doi: 10.1186/s12958-021-00727-3.
M. M. Abdel-Daim, O. S. El-Tawil, and R. H. Abdou, “Testicular injury and impaired spermatogenesis following cisplatin treatment: protective role of natural antioxidants,” Biomed. Pharmacother., vol. 132, p. 110909, 2020, doi: 10.1016/j.biopha.2020.110909.
O. Ojo, E. Omoregie, and A. Obi, “Protective effects of antioxidant-rich agents against chemotherapy-induced testicular toxicity,” Andrologia, vol. 55, no. 2, p. e14601, 2023, doi: 10.1111/and.14601.
I. Arany and R. L. Safirstein, “Cisplatin nephrotoxicity,” Semin. Nephrol., vol. 23, no. 5, pp. 460–464, 2003, doi: 10.1016/S0270-9295(03)00089-5.
E. A. Salem, N. A. Salem, and A. M. Maarouf, “Antioxidant role of vitamin E and selenium in cisplatin-induced testicular toxicity in rats,” Andrologia, vol. 53, no. 4, p. e13995, 2021, doi: 10.1111/and.13995.
L. M. Cruz-Orive, “Precision of systematic sampling in stereology: prediction and estimation of variance in morphometric studies,” J. Microsc., vol. 193, no. 3, pp. 189–198, 1999, doi: 10.1046/j.1365-2818.1999.00457.x.
J. Shah, D. Patel, and A. Patel, “Cisplatin-induced testicular dysfunction and the protective role of flavonoids: a systematic review,” Curr. Drug Metab., vol. 23, no. 1, pp. 41–49, 2022, doi: 10.2174/1389200223666220310105912.
T. E. Sener, V. Tugcu, and E. Ozbek, “Protective effect of resveratrol against cisplatin-induced testicular damage in rats,” Andrologia, vol. 52, no. 5, p. e13570, 2020, doi: 10.1111/and.13570.
B. M. Patel, “Emerging role of antioxidants in the protection against chemotherapy-induced testicular toxicity,” Biomed. Pharmacother., vol. 139, p. 111623, 2021, doi: 10.1016/j.biopha.2021.111623.
N. M. Saeed and M. H. Hassan, “Effect of selenium and zinc supplementation on cisplatin-induced reproductive toxicity in rats,” J. Trace Elem. Med. Biol., vol. 75, p. 127069, 2023, doi: 10.1016/j.jtemb.2022.127069.
H. E. Mohamed, F. K. El-Baz, and A. A. Ahmed, “Role of nano-curcumin in ameliorating testicular toxicity induced by cisplatin in rats,” Toxicol. Rep., vol. 9, pp. 1443–1451, 2022, doi: 10.1016/j.toxrep.2022.09.001.
R. M. Elgharabawy and S. H. Ahmed, “Chemoprotective effects of Moringa oleifera extract on testicular damage in cisplatin-treated rats,” Environ. Sci. Pollut. Res. Int., vol. 27, no. 34, pp. 42923–42931, 2020, doi: 10.1007/s11356-020-10340-6.
G. Ahmad, M. Qasim, and R. Bano, “Protective effects of quercetin against chemotherapy-induced testicular damage in experimental models: A review,” Antioxidants, vol. 10, no. 3, p. 423, 2021, doi: 10.3390/antiox10030423.
M. Badawy and M. I. El-Sayed, “Role of N-acetylcysteine in restoring fertility parameters altered by cisplatin chemotherapy in male rats,” Hum. Exp. Toxicol., vol. 41, p. 9603271221105247, 2022, doi: 10.1177/09603271221105247.
A. Ghosh and K. Jana, “Cisplatin-induced oxidative stress and reproductive toxicity: an update,” Reprod. Toxicol., vol. 104, pp. 135–143, 2021, doi: 10.1016/j.reprotox.2021.05.008.
S. Yilmaz, A. Atessahin, and E. Sahna, “Protective effects of lycopene on cisplatin-induced changes in sperm characteristics, testicular damage and oxidative stress in rats,” Reprod. Toxicol., vol. 93, pp. 38–45, 2020, doi: 10.1016/j.reprotox.2019.12.002.
L. Zhang, Y. Zhang, and Y. Chen, “Mitochondria-targeted antioxidant reverses cisplatin-induced testicular damage,” Free Radic. Biol. Med., vol. 199, pp. 1–10, 2023, doi: 10.1016/j.freeradbiomed.2023.02.002.
Z. Heidari and M. Salami, “Histological and ultrastructural evaluation of the testes after cisplatin and protective effects of crocin in rats,” Tissue Cell, vol. 74, p. 101700, 2022, doi: 10.1016/j.tice.2021.101700.
Copyright (c) 2025 Joynarov Y.U., Ishburiev N.R, Shermatov U.M, Abulfayzov Z.Sh, Djuraev M.O
This work is licensed under a Creative Commons Attribution 4.0 International License.
